HHS Secretary Robert F. Kennedy Jr., confirmed by a 52-48 Senate vote on February 13, 2025, continues to lead the department amid recent congressional scrutiny, including April 2026 hearings on the Trump administration's health policy and proposed 12% budget cuts where he defended his Make America Healthy Again agenda despite Democratic calls for resignation. Trader consensus at 75% on "No" reflects his entrenched position, with no verified reports of withdrawal, firing, or sidelining—only routine leadership shakeups in February 2026 and ongoing appeals of court rulings blocking vaccine policy overhauls. Upcoming midterm elections and policy deadlines could pressure his tenure, but current stability drives the odds favoring his continuation past December 31, 2026.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado$16,149 Vol.
$16,149 Vol.
$16,149 Vol.
$16,149 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado abierto: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...HHS Secretary Robert F. Kennedy Jr., confirmed by a 52-48 Senate vote on February 13, 2025, continues to lead the department amid recent congressional scrutiny, including April 2026 hearings on the Trump administration's health policy and proposed 12% budget cuts where he defended his Make America Healthy Again agenda despite Democratic calls for resignation. Trader consensus at 75% on "No" reflects his entrenched position, with no verified reports of withdrawal, firing, or sidelining—only routine leadership shakeups in February 2026 and ongoing appeals of court rulings blocking vaccine policy overhauls. Upcoming midterm elections and policy deadlines could pressure his tenure, but current stability drives the odds favoring his continuation past December 31, 2026.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes